Camlin Fine Sciences Ltd Quarterly Results

Gross Sales

433.49

422.97

395.85

401.69

385.89

Excise Duty

0

0

0

0

0

Net Sales

433.49

422.97

395.85

401.69

385.89

Other Operating Income

0

0

0

0

0

Other Income

1.34

12.6

1.87

5.76

1.66

Total Income

434.83

435.57

397.72

407.46

387.55

Total Expenditure

386.55

530.77

377.72

464.75

362.56

PBIDT

48.28

-95.19

20.01

-57.29

24.99

Interest

34.12

26.42

23.37

16.17

14.14

PBDT

14.15

-121.62

-3.37

-73.46

10.85

Depreciation

14.48

20.69

20.11

20.05

20.58

Minority Interest Before NP

0

0

0

0

0

Tax

4.32

16.41

7.4

6.51

6.48

Deferred Tax

2.82

-42.61

3.77

-18.23

-1.94

Reported Profit After Tax

-7.47

-116.11

-34.65

-81.79

-14.28

Minority Interest After NP

-3.34

-15.88

-0.7

-4.65

-2.49

Net Profit after Minority Interest

-4.14

-100.23

-33.95

-77.14

-11.79

Extra-ordinary Items

0

-134.62

0

-46.33

0

Adjusted Profit After Extra-ordinary item

-4.14

34.39

-33.95

-30.81

-11.79

EPS (Unit Curr.)

-0.24

-5.98

-2.03

-4.64

-0.71

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

16.75

16.75

16.75

16.75

16.75

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

11.13

-22.5

5.05

-14.26

6.47

PBDTM(%)

3.26

-28.75

-0.85

-18.28

2.81

PATM(%)

-1.72

-27.45

-8.75

-20.36

-3.7